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Abstract 
Aims/hypothesis. Osmotic and oxidative stresses are associated with the progression and 
advancement of diabetic cataract. In the present study, we used a cDNA microarray method to 
analyze gene expression patterns in streptozotocin (STZ)-induced diabetic and galactose-fed 
cataractous lenses. In addition, we investigated the regulation and interaction(s) of antioxidant 
protein 2 (AOP2) and LEDGF in these models.  
Methods. To identify differential gene expression patterns, one group of Sprague-Dawley rats 
was made diabetic with STZ and a second group was made galactosemic. Total RNA was 
extracted from the lenses of both groups and their controls. Labelled cDNA was hybridized to 
Atlas™ Rat Arrays (Clontech). Changes in gene expression level were analyzed. Real-time PCR 
and western analysis were used to validate the microarray results.  
Results. The expression of 31 genes was significantly modulated in hyperglycemic lenses 
compared with galactosemic lenses. Notably, transcript and protein levels of bcl-2 and NF-κB 
were significantly elevated in rat lenses at 4 weeks after injection of STZ. mRNA and protein 
levels of TGF-β were elevated at a later stage. However, levels of mRNA for IGF-1, LEDGF and 
AOP2 were diminished in STZ-induced diabetic cataract.  
Conclusions/interpretations.  These results provide evidence that progression of sugar cataract 
involves oxidative- and TGF-β-mediated signaling. These pathways may promote abnormal 
gene expression in the hyperglycemic and galactosemic states and thus may contribute to the 
pathologies associated with these conditions. Since oxidative stress seems to be a major event in 
cataract formation, supply of antioxidant may postpone the progression of such disorders.  
 
Keywords. cDNA microarray, Diabetic cataract, Galactose cataract, Oxidative stress, Polyol 
pathway 
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Abbreviations: STZ, streptozotocin; AOP2, antioxidant protein 2; AR, aldose reductase; 
ARI, aldose reductase inhibitor; bcl2, B-cell leukemia/lymphoma protein 2; CT, cycle 
threshold; ESTs, expressed sequence tags; hLECs, human lens epithelial cells; Hsp, heat 
shock protein; LEDGF, lens epithelium derived growth factor; PKC, protein kinase C; 
ROS, reactive oxygen species  
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Introduction 
Diabetic eye disease develops as a complication of long-term diabetes and is the most 
common cause of blindness. Diabetic cataract is a leading cause of vision loss in younger 
patients. Surgery is the only treatment for diabetic cataract, but after surgery the 
progression of diabetic retinopathy is often accelerated by the breakdown of the 
blood-aqueous barrier[1]. Furthermore, anterior capsular contraction[2, 3] and posterior 
capsular opacification[4] are induced earlier in diabetic patients than in non-diabetic 
patients following cataract surgery and intraocular lens implantation. The development of 
more effective therapies requires a precise understanding of the molecular mechanisms 
causing disease, providing a basis for a rational approach to therapy.  
Hyperglycaemia triggers the activation of the aldose reductase (AR)/sorbitol pathway, 
nonenzymatic glycation of lens fibers and oxidative stress [5-8]. In the lens, osmotic 
stress imposed by sorbitol accumulation has long been believed to be the major factor in 
the progression of diabetic cataract [6-11]. Activation of the AR/sorbitol pathway also 
increases oxidative stress by elevating levels of hydrogen peroxide[12] and free 
radicals[13]. The involvement of the polyol pathway in generation of 
hyperglycaemia-induced oxidative stress has been demonstrated in diabetic lenses [7, 8, 
14]. We have reported that human lens epithelial cells (hLECs) overexpressing AR are 
susceptible to apoptosis under hyperglycaemic conditions, and that supply of an AR 
inhibitor and/or anti-oxidant protein 2 (AOP2) was able to protect these cells from 
hyperglycaemia-induced apoptosis [15]. We have used streptozotocin (STZ)-induced 
diabetes in rats as an animal model of type 1 diabetes, and galactose-fed rats have been 
studied as animal models for sugar cataracts[7, 8, 11]. Lenticular polyol accumulation 
was the primary event in these models for the induction of cataractogenesis, and 
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progression of sugar-induced cataract depended on the level of serum glucose or 
galactose[7]. However, disease severity increased as the diabetes progressed, and nearly 
all diabetic patients are susceptible to the development of cataract. 
 Among the several studies of the mechanism of progression of diabetic cataract and 
its complications, none has explored the profiling of global gene expression. Importantly, 
oxidative stress and osmotic stress are both believed to be involved in the pathogenesis of 
diabetic as well as sugar cataract, with a major role proposed for osmotic stress in the 
latter disorder [14-16]. Analysis of individual genes has begun to define some critical 
stages in the progression of hyperglycaemia- or galactocaemia-induced cataractogenesis, 
yet the complex interaction(s) of extracellular signals and responding genetic networks 
that control lens physiology are largely unstudied. Since global changes in gene 
expression underlie developmental processes in pathogenesis, we expect, by using cDNA 
microarray analysis, to reveal signaling pathways and biomolecules important for the 
development of diabetic cataract.  
In the present study, we used cDNA microarrays from Clontech to analyze 
systematically the genes that are modulated and also to define the genes that are common 
to both etiologies or specific for one of them. The design of our study is as follows.  First, 
we used lenses from the early stages of galactocaemic and hyperglycaemic cataracts and 
their respective age-matched controls. Secondly, we compared both spatial and temporal 
expression profiles in each group to define more fully the common or specific genes 
characteristic of each condition. Thirdly, we validated our profiles by demonstrating the 
galactocaemic- and/or glycaemic-specific expression of certain genes by real time PCR 
and western blot analysis. The present study provides novel and detailed insights into 
gene networks activated in lenses or LECs facing galactocaemic and hyperglycaemic 
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assault. Furthermore, knowledge of dysregulated gene expression, together with detailed 
studies on the relevant signaling pathways and their uniqueness in both cataract groups, 
may provide opportunities for the rational development of drugs to delay and prevent the 
onset of these conditions.   
 
Materials and methods 
Animals. All animal experiments followed the recommendations of the ARVO Statement 
for the Use of Animals in Ophthalmic and Vision Research. We used 4-week-old 
Sprague-Dawley albino rats, which were obtained from a local animal dealer (Clea Japan 
Inc., Osaka, Japan). Diabetic cataract was induced in 20 rats by a single intraperitoneal 
injection of 80 mg/kg body weight STZ (Sigma, St. Louis, MO, USA) in 0.05mM citrate 
buffer (pH 4.5) after they had been fasted overnight [17]. These STZ-injected rats were 
given ad libitum access to regular chow consisting of 25% (w/w) protein, 53% 
carbohydrate, 6% fat and 8% water (Oriental Yeast Co. Ltd., Osaka, Japan) for 4 or 12 
weeks (STZ4W and STZ12W groups). At the 4th week after injection of STZ, all rats had 
blood glucose levels >600 mg/ml (33.4mmol/l). For induction of sugar cataract, ten rats 
were given ad libitum access to 50% D-galactose mixed with regular chow for 4 or 14 
days without injection of STZ  (Gal4d and Gal14d groups). The eyes of these animals 
were monitored daily to assess the progression of cataract by following the method of 
[13].At predefined times, the animals were sacrificed and RNA was harvested from their 
lenses. RNA from age–matched animals was used as controls.   
 
RNA extraction from lens. At 4 weeks after STZ injection, and on day 4 of galactose 
feeding, 5 rats from each group were euthanized with CO2. Lenses were extracted from 
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these rats and immediately frozen in liquid nitrogen. 8-week-old rats were also used for 
the study and the gene profiles were compared. Total RNA from each sample was 
extracted with the Atlas™ Glass Total RNA Isolation Kit (Clontech, Palo Alto, CA, USA) 
by following the manufacturer’s protocol and . Lenses from control rats were used to 
isolate RNA that served as the controls. Samples of RNA were set aside for real time PCR 
to verify the results obtained from the microarray analysis. Agarose gel electrophoresis 
was performed to assess RNA integrity. Each isolated total RNA had a 28S to 18S ratio of 
1.5. 
 
RNA labeling and hybridization. The Atlas™ Glass Fluorescent Labeling Kit (Clontech) 
was used for RNA labeling. Briefly, for each labeling, 20μg of total RNA was reverse 
transcribed in the presence of CDS primer mix and MMLV reverse transcriptase. Cy3 
fluorescent dye (Amersham Pharmacia, Piscataway, NJ, USA) was coupled to the first 
strand cDNA. Labelled cDNA was hybridized to Atlas™ Glass Rat 1.0 Arrays (Clontech) 
according to the manufacturer’s protocol. Briefly, labelled cDNA was mixed with 
preincubated GlassHyb Hybridization Solution at 50°C. Hybridization solution 
containing labelled cDNA was hybridized to the glass array in the hybridization chamber 
at 50°C. After overnight hybridization with the labelled probe, each glass slide was 
washed once in GlassHyb Wash Solution, twice in 1×SSC (15mmol trisodium citrate and 
150 mmol NaCl) and once in 0.1×SSC at room temperature. Air-dried slides were 
scanned with a fluorescent slide scanner. Scanned images were analyzed with 
ArrayGauge software (Fuji Photo Film, Tokyo, Japan).  
 
Microarray procedure and statistical analysis. Atlas™ Glass Rat 1.0 Microarrays were 
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purchased from Clontech and used for the experiment. Briefly, the array contains 1081 
genes, represented by well-characterized single-strand cDNA fragments and excluding 
expressed sequence tags (ESTs), which can often be redundant and misrepresentative, 
and is printed on a DNA Ready Type II slide. Each rat gene is represented by an 80-base 
oligonucleotide. 
Atlas™ Iris software (Clontech) was used to normalize the 1081 genes for overall 
background and to compare the experimental slides. The -fold change(s) in gene 
expression in the galactose or STZ groups versus the control group was calculated, and 
genes that were differentially expressed to a statistically significant extent were identified 
with the Atlas™ Iris software. 
 
Real time PCR. To validate the gene expression patterns obtained from microarray 
analysis, relative quantification of mRNA was performed with LightCycler-RNA Master 
SYBRGreen I (Roche, Mannheim, Germany).  At 4 and/or 12 weeks after STZ injection, 
5 rats from each group were euthanized with CO2. To avoid amplification of genomic 
DNA sequences, all RNA samples were treated with DNase I and diluted to 100 ng/μl. All 
reactions were carried out in a single tube reaction setup on the LightCycler system 
(Roche). The following temperature profile was used: 20 min at 61°C for reverse 
transcription and 30s at 95°C for denaturation of cDNA/RNA hybrid, followed by 45 
cycles of 5s at 95°C, 5s at 55°C and 13s at 72°C. The cycle threshold (Ct) was used to 
calculate relative amounts of target RNA. Table 1 summarizes the sequences and sources 
of primers used in this study. Samples that do not reach the threshold line are considered 
not above background. The Cts of target genes were normalized to the levels of beta-actin 
as an endogenous control in each group. The average Ct for each gene is calculated by 
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subtracting the Ct of the sample RNA from that of the control RNA for the same time 
measurement. This value is known as the ΔCt and reflects the relative expression of the 
treated sample compared with the control and becomes the exponent in the calculation for 
amplification 2ΔCtcont-ΔCtsample, equivalent to -fold change in expression. Unpaired student 
t-test was used for statistical analysis.  
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Western blot analysis. At 4 and 12 weeks after STZ injection (STZ4W and STZ12W 
groups) and on days 4 and 14 of feeding of 50% galactose (Gal4d and Gal14d groups), 5 
rats from each group were euthanized with CO2. Tissue lysates of lenses were prepared in 
ice-cold RIPA buffer as described previously[18]. The protein concentration of each 
supernatant was determined by the Lowry assay[19]. 20μg of protein was loaded and run 
on a 10-20% SDS-PAGE gradient gel and transferred to a PVDF membrane (BioRad 
Laboratories, Hercules, CA, USA). Membranes were blocked with 5% milk, and were 
incubated overnight at 4°C with anti-mouse B-cell leukemia/lymphoma protein 2 (bcl-2) 
monoclonal Ab, anti-rabbit bax polyclonal Ab (Santa Cruz Biotechnology Inc., Santa 
Cruz, CA, USA), anti-rabbit lens epithelium derived growth factor (LEDGF) polyclonal 
Ab described elsewhere[18] previously, and anti-rabbit AOP2 polyclonal Ab (dilution 
1:1000-4000). After being washed, the membranes were incubated with anti-mouse or 
anti-rabbit IgG labelled with horseradish peroxidase (diluted 1:2000; Santa Cruz 
Biotechnology) and visualized by the enhanced chemiluminescence method according to 
the manufacturer’s protocol (Santa Cruz Biotechnology). The same dilutions of absorbed 
Abs to the various molecules were used as negative controls. Anti-rabbit actin Ab (Santa 
Cruz Biotechnology) was used to show that the equal amount of protein was loaded in 
each lane. 
 
Results 
Cataracts in STZ-injected and galactose-fed rats. Some peripheral vacuoles in the 
equatorial cortical regions were observed in the STZ4W group and the Gal4d group. 
Cortical cataract progressed to the entire lens surfaces in the STZ12W and Gal14d 
groups . These lenses were used for gene expression profiling and were compared within 
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and between the groups. 
 
Analysis of gene expression profile. Scattergrams of mRNA expression demonstrating the 
differences between the control lens and those from the STZ4W and Gal4d groups are 
shown in Fig. 1. The changes in the expression of majority of genes were within 3-fold 
(Fig. 1). There were 83 genes in the STZ4W group and 29 genes in the Gal4d group that 
showed significant changes of greater than 2.5-fold (ESM). In the STZ4W group, 64 
genes were significantly up-regulated and 19 genes were significantly down-regulated 
(ESM). In the Gal4d group, 22 genes were significantly up-regulated and 7 genes were 
significantly down-regulated (ESM). Differentially regulated genes in these rat lenses 
could be classified into 17 groups: (1) cell surface antigens, (2) transcription factors, 
activators and repressors, (3) cell cycle, (4) cell adhesion receptors/proteins, (5) 
extracellular transport/carrier proteins, (6) stress response proteins, (7) membrane 
channels and transporters, (8) trafficking/targeting proteins, (9) metabolism, (10) 
apoptosis-associated proteins, (11) DNA-binding and chromatin proteins, (12) cell 
receptors (by ligands), (13) cell signaling and extracellular communication proteins, (14) 
intracellular transducers/effectors/modulators, (15) protein turnover, (16) cell receptors 
(by activities) and (17) functionally unclassified. 
Twenty-three genes that were up-or down-regulated by more than 2.5-fold relative to 
the control were common to both the STZ4W and Gal4d groups. However, the most 
highly up-regulated gene common to both groups was bcl-2, an anti-apoptotic associated 
protein, which showed more than 30-fold higher expression compared with the control. 
The transcriptional factor NF-κB, an activator of the AR gene[20], was up-regulated in 
both groups (ESM). Expression levels of TGF-β1 and 3, IGF-1 and IGF binding protein 
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were diminished in both the STZ4W and/or Gal4d groups. Analysis of the gene 
expression patterns of the STZ and galactose groups demonstrates a common pattern of 
expression of certain genes, specifically those associated with oxidative stress. However, 
our study demonstrates that the role of oxidative stress is predominant in the STZ group, 
whereas both osmotic and oxidative stress are implicated in cataractogenesis in the 
galactose group. 
 
Real-time PCR analysis of mRNA expression. Next, we verified the up- or 
down-regulation of expression of selected genes in both groups by real time PCR. NF-κB, 
bcl-2, TGF-β3, IGF-binding protein and IGF-1 were selected on the basis of the results 
from the microarray study in the STZ4W group (Fig. 2). NF-κB mRNA was up-regulated 
at the 4th and 12th weeks after STZ injection (p<0.003). On the other hand, TGF-β3 
mRNA expression was down-regulated at the 4th week (p<0.001) and up-regulated at the 
12th week (p<0.002) (Fig. 2). IGF-binding protein and IGF-1 were down-regulated at the 
4th and 12th weeks (p<0.01) after STZ injection (Fig. 2). Real time PCR showed that bcl-2 
mRNA expression was up-regulated at the 4th week (p<0.001) and normalized at the 12th 
week (Fig. 2).  Next, we examined transcription levels of the oxidative stress-associated 
as well as apoptosis-associated genes LEDGF and AOP2 [21-27]. We found that LEDGF 
and AOP2 mRNAs were down-regulated in rat lenses at the 4th and 12th weeks after STZ 
injection (Fig. 3) (LEDGF; p<0.01, AOP2; p<0.001), suggesting that supply of 
antioxidant protein may prevent hyperglycaemia-induced complication(s). 
 
Protein blot analysis of oxidative stress-associated and apoptosis-related genes in 
STZ-injected and/or galactose-fed rats. Since elevation of gene transcription is not 
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always associated with gene translation, we examined the protein levels of selected 
relevant biomolecules, including the apoptosis-related bcl-2 and bax, the apoptosis- and 
oxidative stress-related transcriptional factor LEDGF, and AOP2, also known as 
peroxiredoxin 6. Our analysis revealed elevated bcl-2 protein expression in lenses at the 
4th week after STZ injection and the 4th day of 50% galactose feeding, but reduced 
expression at the 12th week after STZ injection and the 14th day of 50% galactose feeding 
(Fig. 4a and b). On the contrary, the pro-apoptotic protein bax was up-regulated in STZ 
rats, especially at the 12th week after STZ injection (Fig. 4c). LEDGF and AOP2 were 
down-regulated in STZ rat lenses (Fig. 5a and b). There was no significance difference in 
LEDGF and AOP2 protein expression levels between the STZ4W and STZ12W groups 
(Fig. 5a and b). 
 
Discussion 
Oxidative stress may result from an increase in free radical production and/or a decrease 
in antioxidant defenses because of environmental stressors[28].  High glucose levels 
attenuate the function of LECs through the generation of free radicals [13, 16, 29], 
suggesting a possible pathophysiological linkage between the high level of glucose and 
balance of antioxidants. Our study revealed decreased expression of AOP2 mRNA and 
protein in the lenses of rats with diabetes- or galactose-induced cataracts. This is 
consistent with our previous observations that hyperglycaemia causes a decrease of this 
protein in lens epithelial cells and that these cells subsequently undergo apoptosis.  
However, the aim of this study was to define more precisely the novel family of genes 
that provide a sustained response to deleterious signals from reactive oxygen species 
(ROS) generated during hyperglycaemia or from osmotic stress due to hyperglycaemia  
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and galactocaemia. To do so, we obtained lenses from rats with glucose-induced (STZ) or 
galactose-induced cataracts at different stages, isolated total RNA and performed 
microarray analysis. Using this approach, we identified several subsets of genes that 
continue to respond to ROS signaling. For example, the transcription factors NF-κB and 
AP1 are redox active and are highly expressed during hyperglycemia. At the 4th week 
after STZ injection, and on the 4th day of galactose feeding, 83 genes in the STZ group 
and 29 genes in the galactose group were significantly up- or down-regulated out of the 
1081 genes analyzed (ESM). In the STZ group, 64 genes showed more than 2.5-fold 
up-regulation and 19 genes showed more than 2.5-fold down-regulation compared with 
the control. In the galactose group, 22 genes showed more than 2.5-fold up-regulation and 
7 genes showed more than 2.5-fold down-regulation compared with the control. In the 
STZ group, up-regulated genes were classified into 16 groups and down-regulated genes 
were classified into7 groups (ESM). In the galactose group, up-regulated genes were 
classified into 10 groups and down-regulated genes were classified into 3 groups (ESM).  
Although all the genes (listed in ESM) may be of interest, it was not possible to study 
all of them. Lenticular polyol accumulation initiated by AR has been considered a 
principal factor in the etiology of sugar cataract, such as STZ cataract and galactosaemic 
cataract[6-9, 30] . Among the 22 up-regulated genes in the galactose group, 16 genes 
were up-regulated similarly in the STZ group. Among the 7 down-regulated genes in the 
galactose group, 3 genes were down-regulated similarly in the STZ group. Diabetes in 
STZ-treated rats results from the STZ-mediated destruction of the insulin-producing β 
cells in the pancreas[17, 31]. Gene expression changes in STZ rats could be induced not 
only by AR-mediated osmotic or oxidative stress but also by insulin depletion or by β 
cell-destruction-mediated factors. Thus, special attention was paid to the set of genes that 
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showed more than 4-fold up- or down- regulation in both groups, and mRNA expression 
levels of these genes were confirmed by real time PCR. Moreover, sorbitol is a polyol 
osmolyte synthesized from glucose by the enzyme AR. High plasma glucose 
concentrations increase intracellular glucose concentrations in cells permeable to glucose 
and force an increase in sorbitol synthesis by mass action[32]. The accumulation of 
sorbitol may damage cells in eye, in part by inducing a reciprocal loss of other volume 
regulatory solutes such as myo-inositol and taurine[33]. In LEC, the accumulation of 
sorbitol accompanies the ultrastructural changes that commonly occur in diabetes and is 
believed to cause cell swelling as an initial events in cataract formation. Thus, there are 
several factors that may be involved in gene transcription. Under hypertonic conditions, 
however, sorbitol accumulation occurs and is accompanied by almost up-regulation of 
both transcription and translation of gene encoding for the sodium dependent 
myo-inositol co transporter [34]. Evidence to date implicating the polyol pathway in the 
pathogenesis of diabetic complications has been considered. Present study demonstrates 
various redox active genes are up-regulated. How these genes are associated with specific 
stage of disease need to be investigated. Moreover, the gene for the transcriptional factor 
NF-kB was up-regulated in both groups in microarray analysis, and real time PCR 
showed time-dependent increases in its mRNA expression level after STZ injection (ESM 
and Fig. 2). It has been reported that hypertonic induction of AR mRNA is induced by 
activation of NF-κB and its binding to the osmotic response element of the AR 
promoter[20, 35, 36]. AR-dependent metabolism is essential for cytokine- and high 
glucose-mediated cell death, and the inhibition of AR prevents redox-sensitive events 
preceding the activation of PKC and NF-κB[36]. However, increased levels of NF-κB 
transcript in sugar cataract may be related to the induction of AR expression and of 
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apoptosis in the lens.  
TGF-β1 and 3 were down-regulated in the STZ4W and/or Gal4d groups and TGF-β3 
was up-regulated in the STZ12W group. TGF-β has been reported to induce 
morphological changes similar to those in human anterior subcapsular cataract. Anterior 
and posterior subcapsular cataracts are typically observed in diabetic patients. TGF-β, a 
potent inducer of matrix protein synthesis, may be a candidate mediator of the 
morphological changes observed in diabetic cataract. In addition, our results indicate 
activation of TGF-β signaling in diabetic and galactocaemic conditions (Fig. 3). We 
believe that NF-κB signaling is suppressed by TGF-β. Furthermore, hyperglycaemia- 
induced oxidative stress (ROS/H2O2) and ROS themselves are known inducers of 
bioactive TGF-β[37, 38]. Furthermore, decline in antioxidants has been reported in 
diabetes, providing a further reason for TGF-β activation [14, 16]. 
In humans, increases in serum and vitreous IGF-1 levels have been found in patients 
with poorly controlled diabetes[39]. However, IGF-1 and IGF-1 binding protein were 
down-regulated in the STZ4W and STZ12W groups, but not in the Gal4d group. The 
level of mRNA for IGF-1 in diabetic rats differs among tissues, and expression of IGF-1 
mRNA in liver and stomach was lower in STZ-diabetic rats than in normal rats [39, 40]. 
Our data show that lenticular expression of IGF-1 and IGF-1 binding protein mRNAs 
was lower in diabetic rats than in normal animals. Insulin depletion in STZ-diabetic rats 
may be the cause of the lower IGF-1 level in the lens. In the present study, mRNA for the 
anti-apoptotic protein bcl-2 was more than 30-fold up-regulated in both groups by 
microarray analysis (ESM), and we confirmed this over-expression of bcl-2 in sugar 
cataract by real-time PCR in the STZ4W and STZ12W groups. Interestingly, bcl-2 
transcripts were 2.2-fold up-regulated at 4 weeks in the STZ-treated rats and decreased to 
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about the control level by 12 weeks (Fig. 3). However, bcl-2 expression was found 
up-regulated, we wondered about the data obtained from real time-PCR (2.5 fold) and 
microarray (30 fold) regarding bcl2 expression. This discrepancy may be due to presence 
of splicing variants or some other technical problems. In some cell lines, 
bcl-2-overexpressing cells show greater resistance to various pro-oxidants than do 
mock-transfected cells[41-43]. However, in other cell lines, expression of bcl-2 does not 
protect the transfected cells against oxidative stress[44, 45]. In rabbit lens epithelial cells, 
bcl-2-transfected cells are more susceptible to H2O2-induced apoptosis than are control 
cells[46]. In the present study, up-regulation of bcl-2 was observed in early (4 weeks) 
cortical cataracts in STZ-treated rats. It is not clear whether an anti-apoptotic pathway is 
active in these early cataracts, but up-regulation of the apoptotic protein bax and 
normalized levels of bcl-2 were observed in cataractous lenses 12 weeks after STZ 
treatment. It has been reported that bcl-2 increases the susceptibility of rabbit LECs to 
H2O2-induced apoptosis, an effect mediated by down-regulation of the αB-crystallin gene 
as a result of changed activity of LEDGF[46]. LEDGF is a newly identified 
transcriptional factor[25, 47-49] and is homologous to p75, a known co-activator of 
transcription and pre-mRNA splicing[50-52]. LEDGF mRNA and protein are activated 
and up-regulated by heat and oxidative stress and enhances cellular survival[22]. In our 
study, LEDGF and AOP2 mRNA and protein levels were down-regulated in lenses from 
STZ-treated rats after 4 and 12 weeks. We have reported that AOP2 can protect against 
hyperglycaemia-induced apoptosis in hLECs[15]. Down-regulation of LEDGF and 
AOP2 would increase oxidative stress in lenses from STZ-treated rats. In turn, increased 
oxidative stress and osmotic stress would induce apoptosis and lens fiber swelling of lens 
epithelial cells, leading to sugar cataract in STZ-treated rats. It is our intention to 
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determine whether or not up-regulation of bcl-2 can induce down-regulation of AOP2. 
We conclude from this study that a large number of factors are involved in the 
initiation and progression of sugar cataract. However, the expression patterns of several 
genes, such as NF-κB, bcl-2 and bax, were similar in the STZ-treated and galactose-fed 
groups. From these results, we speculate that activation of the polyol pathway may lead to 
osmotic and oxidative stress that regulates gene expression in lenses from STZ-treated 
and galactose-fed rats. Importantly, these findings indicate that the induction and 
progression of both diabetic and galactocaemic cataract may be associated with abnormal 
redox signaling caused by the presence of TGF-β. However, the differential expression of 
several genes in hyperglycaemic and galactocaemic cataract suggests the involvement of 
separate and novel signaling pathways in their pathogenesis.  These findings may suggest 
mechanisms that lead to the induction of survival-inhibitory genes in diabetic cataractous 
lenses and provide an approach to reproducing the effects of survival genes such as 
LEDGF and antioxidant genes such as AOP2. In turn, application of this knowledge may 
lead to therapies able to postpone the onset or progression of diabetic cataract. 
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Table1. Primer Sets used for real time PCR 
 
 
 
 
 
 
 
 
 
  
Gene name Primer Sequence Product Size (bp) 
NF-κB Forward;5’ tcttcgactacgcggttacgggag 3’ 127 
 Reverse; 5’ catcatccaccttcatgctcagct 3’  
bcl-2 Forward;5’ gggatgcctttgtggaacta 3’ 138 
 Reverse; 5’ ctcacttgtggcccaggtat 3’  
TGF-β3 Forward;5’ aatctgcccacgagaggcaccgc 3’ 138 
 Reverse; 5’ catgtcatacctttcagcccaat 3’  
IGF-binding protein Forward;5’ acaccgagtctggcttcact  3’ 138 
 Reverse; 5’ gaacactgtgtcaggcagga  3’  
IGF-1 Forward;5’ ccgctgaagcctacaaagtc 3’ 144 
 Reverse; 5’ gggaggctcctcctacattc 3’  
AOP2 Forward;5’ ccagagtttgccaagaggac  3’ 166 
 Reverse; 5’ tccaatcaactgctgctgtc 3’  
LEDGF Forward;5’ ggggttacgtcaacctctga   3’ 114 
 Reverse; 5’ ttggccttttagcatgttcc  3’  
Beta actin Forward;5’ tgtaaccaactgggacgatatg 3’ 
Reverse; 5’ attagagaagggcgtgctga  3’ 
203 
   
STZ4W Gal4d  Gene Name Up Down Up Down
Cell surface antigens      
U56936 NK lymphocyte receptor; NKR-P1B 9.7  7.1  
Transcription factors, avtivators and 
repressors      
L26267 NF-kappa-B transcription factor p105 subunit (NFKB p105) 5.9  3.0  
X17163 Jun proto-oncogene; transcription factor AP1 3.0  (2.2)  
X91810 Signal transducer & activator of transcription 3 (STAT3) 3.2  - - 
U66479 Mothers against decapentaplegic homolog 3 (MADH3) 5.7  2.5  
Cell cycle      
D28753 + D28754 Cyclin-dependent kinase 2 alpha and beta (CDK2-alpha, beta)  2.8 - - 
Cell adhesion receptors/proteins      
U33553 Neuroglycan C 2.5  - - 
D10831 L-selectin; leukocyte adhesion molecule-1 (LAM-1) 5.5  2.6  
D25290 Cadherin 6; kidney-cadherin (K-cadherin) 2.7  - - 
Extracellular transport/carrier 
proteins      
S46785 Insulin-like growth factor binding protein  4.0 - - 
L33869; J05424 Ceruloplasmin (CERP; CP); ferroxidase 2.7  - - 
Stress response proteins      
M81855 Multidrug resistance protein (MDR1); P-glycoprotein (PGY1) - - 4.1  
D23676 Pancreatitis-associated protein 2 (PAP2); lithostathine 3 4.0  2.8  
Membrane channels and  
transporters      
U88036 Brain digoxin carrier protein 2.6  (1.5)  
X17621 Potassium channel RCK2  3.4 - - 
M30581; J05086 Calcium-transporting sarcoplasmic reticulum type ATPase class 3 isoform (SERCA3; ATP2A3) - - 2.9  
      
AB000113 Cationic amino acid transporter 3 - - 6.2  
X62841 Voltage-gated potassium channel protein 3.4 (KV3.4)  2.7  (2.3)
X61394 Calcium channel, beta subunit, brain 2.6  - - 
M95738 Solute carrier family 6 member 11 (SLC6A11);  4.4  - - 
AF007775 Aquaporin 8 (AQP 8) 3.5  (1.7)  
U77971 Urea transporter 8.9  3.8  
J02649 Potassium-transporting ATPase alpha subunit 3.8  (2.4)  
M55655; J05565 Potassium-transporting ATPase beta subunit (ATP4B) 4.0  (2.3)  
M14512 Sodium/potassium-transporting ATPase alpha 2 subunit  2.9  (1.9)  
Trafficking/targeting proteins      
M95734 Syntaxin 1A (STX1A) 4.7  5.4  
AF000423 Synaptotagmin XI (SYT11) 2.5  (1.8)  
J02762 Asialoglycoprotein receptor R2/3 (ASGPR)  2.8 - - 
L12383 ADP-ribosylation factor 4 (ARF4) 3.5  - - 
L12385 ADP-ribosylation factor 6 (ARF6) 2.6  - - 
Metabolism      
U13253 Fatty acid-binding protein 5 (FABP5)  4.2  (1.9)
U07683 2-hydroxyacylsphingosine 1-beta-galactosyltransferase 2.74  (1.6)  
U07798 Phospholipase A2 group 2C (PLA2G2C) 2.7  -  
U43175 ATPase, subunit F, vacuolar (vatf) - - 2.9  
J02720 Liver arginase 1 (ARG1) 2.8  (2.1)  
Apoptosis associated proteins      
L14680 B-cell leukemia/lymphoma protein 2 (BCL2) 35.8  30.3  
DNA binding and chromatin proteins      
M64986 High mobility group protein 1;HMG1 3.6  (1.5)  
Cell receptors (by ligands)      
D83598 Sulfonylurea receptor 2.8  2.6  
M37394 Epidermal growth factor receptor (EGF receptor; EGFR) 3.4  (1.7)  
X57764 Endothelin receptor ET-B 3.1  (1.6)  
M99418 Gastrin/cholecystokinin type B receptor (CCKBR) 2.6  (2.0)  
X56661 Gastrin-releasing peptide receptor (GRP-R) 3.5  (1.9)  
U47287 Prostaglandin F2 alpha receptor 3.7  (1.6)  
U13368 Alpha 1C adrenergic receptor (ADRA1C) 5.5  3.4  
L02842 Follicle-stimulating hormone receptor (FSHR)  3.4 (2.3)  
U14409 Melatonin receptor 4.5  (1.7)  
L08493 Gamma-aminobutyric-acid receptor alpha 4 subunit (GABA(A) receptor alpha 4; GABRA4)  12.5 - - 
M91562 N-methyl-D-aspartate receptor subtype 2B (NMDAR2B; NR2B) 2.6  (1.5)  
L02529 Frizzled homolog 1 (FZD1; FZ1) - -  2.8 
U42388 Pancreatic polypeptide receptor PP1 - - 4.1  
M22926; J04706 Muscarinic acetylcholine receptor M5 (CHRM5) 3.6  - - 
Cell signaling, extracellular 
communication proteins      
M20373 Neuropeptide Y (NPY) 3.3  (1.5)  
L15305 Glial cell line-derived neurotropic factor (GDNF) - (1.7)  4.6 
U03491 Transforming growth factor beta 3 (TGF-beta3)  4.8  2.7 
M32748 Leukemia inhibitory/cholinergic neuronal differentiation factor (LIF/DIF) 4.1  (1.8)  
M15480 Insulin-like growth factor IB (IGF-IB; IGF1); somatomedin  4.0 - - 
X52498 Transforming growth factor beta 1  2.5  (1.5)
M32167 Glioma-derived vascular endothelial cell growth factor 2.6   4.0 
U22414 Small inducible cytokine subfamily A member 3 (SCYA3) 2.8  - - 
U10156 Somatoliberin; growth hormone-releasing factor) (GRF)  2.8  (1.7)
AF022935 Preprolactin (Prl) 3.8  (1.9)  
AF010464 Interleukin 7 (IL7) 2.6  (2.1)  
Intracellular 
transducers/effectors/modulators      
D45201 Neurofibromin; neurofibromatosis protein type I (NF1) 3.3  - - 
AF007836 RIM; RAB3 effector 34.7  22.4  
S68987; S68989 Set beta isoform + Set alpha isoform 5.0  (2.0)  
U21684 Spleen tyrosine kinase (SYK) 7.5  - - 
L27112 
Mitogen-activated protein kinase 9 (MAPK9); c-jun N-terminal 
kinase 2 (JNK2); stress-activated protein kinase alpha 
(SAPK-alpha) 
3.1  - - 
M18330 Protein kinase C delta type (PKC-delta) 4.5  8.6  
M63334 Calcium/calmodulin-dependent protein kinase type IV (CAMK 
IV) 2.6  - - 
L15618 Casein kinase II (alpha subunit) 2.8  - - 
L42810 Calcium/calmodulin-dependent protein kinase kinase 2.9  - - 
M35862 Mak; male germ cell-associated kinase  2.9 - - 
D64050 Purkinje cells-specific protein tyrosine phosphatase CBPTP  3.0  (1.7)
L19699 Ral B; GTP-binding protein  2.8  (1.7)
M20713 Guanine nucleotide-binding protein G(K) alpha 3 subunit (G(I) 
alpha 3 (GNAI3)  4.3  3.3 
M83680 Ras-related protein RAB14 2.6  - - 
X78605 Ras-related protein RAB4B 4.9  2.5  
J03806 Phospholipase C gamma 1 (PLC-gamma 1; PLCG1) 2.6  2.6  
M80633 Adenylyl cyclase 4 - - 3.1  
D50455 Phospholipase C delta 4 (PLC-delta 4; PLCD4) - 2.5 (1.8)  
L37203 Olfactory guanylyl cyclase D (GUCY2D) 2.8  2.5  
M31178 Calbindin D28 3.2  (1.5)  
D17615 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein zeta polypeptide (YWHAZ) 3.6   3.2 
L02615 Muscle/brain cAMP-dependent protein kinase inhibitor 
(PKI-alpha) 4.8  2.5  
D17445 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein eta polypeptide (YWHAH)  2.8  3.2 
S83440 14-3-3 protein beta/alpha; protein kinase C ingibitor protein-1 2.9  (1.6)  
Protein turnover      
J02997 Dipeptidyl peptidase IV (DPPIV; DPP4) 4.1  (2.1)  
X55986 Proteasome subunit C9 2.9  - - 
Cell receptors (by activities)      
U09357 Receptor protein-tyrosine phosphatase zeta/beta (R-PTP-Z) 2.9  (1.6)  
Functionally unclassified      
U48248 Protein kinase C-binding protein beta15  3.1 (1.9)  
X52711 Myxovirus resistance protein 1 (MX1) 3.4  (2.4)   
 
 
ESM: Known genes abnormally expressed in lenses from STZ-treated or galactose-fed rats. 
 
The table shows a list of known genes, arranged into functional categories, that were found to be either up- or 
down-regulated significantly in both groups. 
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